Brief: Taro Pharmaceutical Industries Reports Q4 EPS $2.17
May 17 (Reuters) - Taro Pharmaceutical Industries Ltd
TARO.N :
* TARO PROVIDES RESULTS FOR YEAR ENDED MARCH 31, 2018
* Q4 EARNINGS PER SHARE $2.17
* Q4 SALES $175.2 MILLION
* FY EARNINGS PER SHARE $6.18 EXCLUDING ITEMS
Source text for Eikon: ID:nBw5ZTn7da
Further company coverage: TARO.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Taro Pharmaceutical Industries
See all newsBrief: Taro Pharmaceutical Industries Says Taro Shareholders Approve Merger With Sun Pharma
Taro Pharmaceutical Industries Ltd reports results for the quarter ended in March - Earnings Summary
Taro Pharmaceutical Industries Ltd expected to post earnings of 31 cents a share - Earnings Preview
Ex-Sandoz exec gets probation for price-fixing after cooperation deal
Brief: ISS, Glass Lewis Recommend Taro Shareholders Vote For Merger With Sun Pharma